Cargando…
A Novel Prognostic Model Based on Ferroptosis-Related Gene Signature for Bladder Cancer
BACKGROUND: Bladder cancer (BC) is a molecular heterogeneous malignant tumor; the treatment strategies for advanced-stage patients were limited. Therefore, it is vital for improving the clinical outcome of BC patients to identify key biomarkers affecting prognosis. Ferroptosis is a newly discovered...
Autores principales: | Yang, Libo, Li, Chunyan, Qin, Yang, Zhang, Guoying, Zhao, Bin, Wang, Ziyuan, Huang, Youguang, Yang, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378228/ https://www.ncbi.nlm.nih.gov/pubmed/34422642 http://dx.doi.org/10.3389/fonc.2021.686044 |
Ejemplares similares
-
Identification of a Novel Ferroptosis-Related Gene Prognostic Signature in Bladder Cancer
por: Sun, Jiale, et al.
Publicado: (2021) -
A Novel Prognostic Signature Based on Ferroptosis-Related Genes Predicts the Prognosis of Patients With Advanced Bladder Urothelial Carcinoma
por: Li, Xiaoqi, et al.
Publicado: (2021) -
Novel Pyroptosis-Related Gene Signatures Identified as the Prognostic Biomarkers for Bladder Carcinoma
por: You, Jia, et al.
Publicado: (2022) -
Identification of Novel Prognostic Risk Signatures of Soft Tissue Sarcoma Based on Ferroptosis-Related Genes
por: Huang, Wenjing, et al.
Publicado: (2021) -
A Novel Ferroptosis-Related 4-Gene Prognostic Signature for Cholangiocarcinoma and Photodynamic Therapy
por: Zhang, Zi-jian, et al.
Publicado: (2021)